These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6602675)

  • 1. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the incorporation of fibronectin into synovial fluid cryoprotein.
    Carsons S; Lavietes BB; Diamond HS
    J Lab Clin Med; 1983 Nov; 102(5):722-31. PubMed ID: 6605399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cryoglobulinemia and fibronectin in systemic lupus erythematosus].
    Baranauskaĭte AA; Nasonov EL; Efremov EE; Kurmanova LV; Eremeeva MV; Solov'ev SK; Kovalev VIu; Lopaeva OV; Kobylianskiĭ AG
    Ter Arkh; 1991; 63(5):75-8. PubMed ID: 1887425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement.
    Sorvillo J; Gigli I; Pearlstein E
    J Immunol; 1983 Sep; 131(3):1400-4. PubMed ID: 6309962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
    Corvetta A; Spaeth PJ; Panico F; Ghirelli PA; Orecchioni F; Danieli G
    G Clin Med; 1983; 64(9-10):337-48. PubMed ID: 6198235
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
    Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
    Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between fibronectin and aggregated IgG].
    Menzel EJ; Borth W; Kaik B
    Wien Klin Wochenschr; 1983 Dec; 95(24):880-4. PubMed ID: 6608184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IgG-bound DNA and C1q-binding materials in iupus nephritis].
    Koyama A; Narita M; Lshida H; Inage H; Sano M; Tojo S
    Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):267-74. PubMed ID: 6981719
    [No Abstract]   [Full Text] [Related]  

  • 13. Location of the binding site in subcomponent C1q for plasma fibronectin.
    Reid KB; Edmondson J
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():11-7. PubMed ID: 6610277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
    Bratt T; Ohlson S
    J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin binds to the C1q component of complement.
    Bing DH; Almeda S; Isliker H; Lahav J; Hynes RO
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4198-201. PubMed ID: 6981115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assay for antigen-antibody complexes in human sera using C1q-enzyme conjugates.
    Stimson WH; McAdam A; Hutchison RS
    J Clin Lab Immunol; 1981 Mar; 5(2):129-31. PubMed ID: 7012357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.